Who is sponsoring NCT05290376?

NCT05290376 is sponsored by Mansoura University.

What drugs are being tested in NCT05290376?

Interventions in NCT05290376: surgical placement of long dental implants, overdenture supported by RTX attachment system.

What condition does NCT05290376 study?

NCT05290376 studies Vertical Alveolar Bone Loss.

Is NCT05290376 still recruiting?

NCT05290376 is currently completed. Last updated 22 March 2022.

Last reviewed 2022-03-22 · How we verify

NCT05290376

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Evaluation of RTX Locator Attachments for Implant-supported Mandibular Complete Overdenture

Completed NA Last updated 22 March 2022

What this trial tests

NA trial testing surgical placement of long dental implants in Vertical Alveolar Bone Loss in 30 participants. Completed in 20 September 2021.

Timeline

15 January 2020

Primary endpoint
15 December 2020

20 September 2021

Quick facts

Lead sponsor	Mansoura University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	15 January 2020
Primary completion	15 December 2020
Estimated completion	20 September 2021
Sites	1 location across Egypt

Drugs / interventions tested

surgical placement of long dental implants
overdenture supported by RTX attachment system

Conditions studied

Vertical Alveolar Bone Loss — all drugs for Vertical Alveolar Bone Loss →

Sponsor

Mansoura University

Who can join

Eligibility, any sex, with Vertical Alveolar Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to clinically and radiographically evaluate locator RTx attachments for two implant-supported mandibular overdenture using two loading protocols

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mansoura University trials

Trials by the same sponsor.

NCT05785377 — Neostigmine as an Adjuvant in Tranversus Abdominis Plane (TAP) Block in Cesarean Section Under Spinal Anesthesia · NA · not yet recruiting
NCT07509567 — Conventional Palatal Crib Versus Bonded Spurs for Anterior Open Bite Treatment · NA · not yet recruiting
NCT07393178 — Efficacy & Safety of High Power vs. Low Power Holmium Laser in Mini-PCNL for Large Renal Stones · NA · not yet recruiting
NCT07436182 — Mitochondrial Redox Modulation in Newly Diagnosed Type 2 Diabetes: A Randomized Controlled Trial Comparing Imeglimin vs. · Phase 4 · not yet recruiting
NCT07534943 — Effectiveness of Oleanolic Acid as Intracanal Medicament on Infectious/Inflammatory Contents in Teeth With Apical Period · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05290376 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mansoura University
Last refreshed: 22 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05290376.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing